Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Feb 06, 2019 8:14pm
144 Views
Post# 29329585

RE:RE:RE:Expectations

RE:RE:RE:Expectations
Pandora wrote:
In theory it sounds great but the last 5 or more years on the Venture Exchange the idea of being diversified has not been a winner -- the marijuana field may be an exception -- which I have stayed away from. All my diversity in small tech, bio, pharma, etc. have all performed exactly the same way. They mostly have gone nowhere. Look at the index over the last 9 years -- where has it gone? There are a few exceptions but I have not been fortunate enough or 'lucky' enough to find them.
It's like the lottery, there's usually a winner and it's pretty much always someone else.
For a major stock market it should not be as bad as it has been.


I don't disagree, TSXV is pretty much dead. I did have some tweed, supreme and others that made me quite a bit more than the bank ever would and easily offset any losses on the others that I owned.. so emerging markets might be better off to play venture/micros. GGI was also initially in a small portfolio of my junior metals that I really like but yes,, it may be more luck these days but if this new poster asking for advice wants to dabble tsxv and TLT, I can only recommend spreading investments out a bit. Don't want crazytrader scolding us.
Bullboard Posts